GlassScriptPhysician profile
Ann M Quesada
NPI 1609826791
$1,711.89
in general payments reported to CMS, 2019-2025
10 companies · $583 in 2025
The $583 reported for 2025 was more than what 89% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $148 · 2022: $147 · 2023: $492 · 2024: $342 · 2025: $583.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,317 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,316.90 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $606.41 | 2023-2025 | Evenity, Prolia |
| Abbvie INC. | $412.02 | 2021-2025 | |
| Astellas Pharma US INC | $224.99 | 2023 | Veozah |
| Foundation Fusion Solutions, LLC | $115.81 | 2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $115.56 | 2022 | |
| Radius Health, INC. | $92.86 | 2025 | Tymlos |
| Mayne Pharma Commercial LLC | $92.24 | 2023 | |
| Mylan Pharmaceuticals INC. | $24.22 | 2021 | |
| Pfizer INC. | $14.86 | 2021 | |
| Agile Therapeutics, INC. | $12.92 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ann Quesada listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.